Letter by Gonzalez and Liebeskind Regarding Article, "Remote Ischemic Limb Preconditioning After Subarachnoid Hemorrhage: A Phase Ib Study of Safety and Feasibility"

被引：2

作者：

Gonzalez, Nestor R. ^{[1
,2
]}

Liebeskind, David S. ^{[3
,4
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Stroke Ctr, Los Angeles, CA 90095 USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA

来源：

STROKE | 2011年 / 42卷 / 09期

关键词：

D O I：

10.1161/STROKEAHA.111.622464

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：E553 / E553

页数：1

共 50 条

[21] Letter by Albertal and Belardi Regarding Article, "Cardiac Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial"
Albertal, Mariano
Belardi, Jorge A.
CIRCULATION, 2009, 120 (14) : E131 - E131
[22] Letter by Chen et al Regarding Article, "Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage"
Chen, Wei
You, Chao
Zheng, Songping
STROKE, 2019, 50 (08) : E233 - E233
[23] Response by Casolla and Cordonnier to Letter Regarding Article, "Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage"
Casolla, Barbara
Cordonnier, Charlotte
STROKE, 2019, 50 (08) : E234 - E234
[24] Response by Rautalin et al Letter Regarding Article, "Smoking Causes Fatal Subarachnoid Hemorrhage: A Case-Control Study of Finnish Twins"
Rautalin, Ilari
Korja, Miikka
Kaprio, Jaakko
STROKE, 2021, 52 (02) : E74 - E75
[25] Letter by Halenarova and Taccone Regarding Article "Impact of Goal-Directed Therapy on Delayed Ischemia After Aneurysmal Subarachnoid Hemorrhage: Randomized Controlled Trial"
Halenarova, Katarina
Taccone, Fabio Silvio
STROKE, 2021, 52 (01) : E19 - E20
[26] Letter by Iliodromitis et al Regarding Article, "Cardiac Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial"
Iliodromitis, Efstathios K.
Kolocassides, Kyriacos G.
Kremastinos, Dimitrios T.
CIRCULATION, 2009, 120 (14) : E130 - E130
[27] In Reply to the Letter to the Editor Regarding "Safety and Efficacy of Noncompliant Balloon Angioplasty for the Treatment of Subarachnoid Hemorrhage-Induced Vasospasm: A Multicenter Study"
Griessenauer, Christoph J.
Patel, Apar S.
Gupta, Raghav
Adeeb, Nimer
Foreman, Paul M.
Shallwani, Hussain
Moore, Justin M.
Harrigan, Mark R.
Siddiqui, Adnan H.
Ogilvy, Christopher S.
Thomas, Ajith J.
WORLD NEUROSURGERY, 2017, 105 : 1023 - 1023
[28] Letter by Rustemi Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])"
Rustemi, Oriela
STROKE, 2017, 48 (04) : e113 - e113
[29] Response to Letter Regarding Article, "Norrin Protected Blood-Brain Barrier via Frizzled-4/β-Catenin Pathway After Subarachnoid Hemorrhage in Rats"
Chen, Yujie
Feng, Hua
Zhang, John H.
STROKE, 2015, 46 (04) : E91 - E91
[30] Response by Hanggi and Macdonald to Letter Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])"
Haenggi, Daniel
Macdonald, R. Loch
STROKE, 2017, 48 (04) : e114 - e114

← 1 2 3 4 5 →